TY - JOUR
T1 - Data-driven monitoring in patients on left ventricular assist device support
AU - Numan, Lieke
AU - Moazeni, Mehran
AU - Oerlemans, Marish I F J
AU - Aarts, Emmeke
AU - Van Der Kaaij, Niels P
AU - Asselbergs, Folkert W
AU - Van Laake, Linda W
N1 - Funding Information:
The collaboration project is co-funded by the PPP Allowance made available by Health-Holland, Top Sector Life Sciences & Health, to stimulate public-private partnerships (LVAD-LVAD, LSHM19035).
Publisher Copyright:
© 2022 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022/9
Y1 - 2022/9
N2 - INTRODUCTION: Despite an increasing population of patients supported with a left ventricular assist device (LVAD), it remains a complex therapy, and patients are frequently admitted. Therefore, a strict follow-up including frequent hospital visits, patient self-management and telemonitoring is needed.AREAS COVERED: The current review describes the principles of LVADs, the possibilities of (tele)monitoring using noninvasive and invasive devices. Furthermore, possibilities, challenges, and future perspectives in this emerging field are discussed.EXPERT OPINION: Several studies described initial experiences on telemonitoring in LVAD patients, using mobile phone applications to collect clinical data and pump data. This may replace frequent hospital visits in near future. In addition, algorithms were developed aiming to early detect pump thrombosis or driveline infections. Since not all complications are reflected by pump parameters, data from different sources should be combined to detect a broader spectrum of complications in an early stage. We need to focus on the development of sophisticated but understandable algorithms and infrastructure combining different data sources, while addressing essential aspects such as data safety, privacy, and cost-effectiveness.
AB - INTRODUCTION: Despite an increasing population of patients supported with a left ventricular assist device (LVAD), it remains a complex therapy, and patients are frequently admitted. Therefore, a strict follow-up including frequent hospital visits, patient self-management and telemonitoring is needed.AREAS COVERED: The current review describes the principles of LVADs, the possibilities of (tele)monitoring using noninvasive and invasive devices. Furthermore, possibilities, challenges, and future perspectives in this emerging field are discussed.EXPERT OPINION: Several studies described initial experiences on telemonitoring in LVAD patients, using mobile phone applications to collect clinical data and pump data. This may replace frequent hospital visits in near future. In addition, algorithms were developed aiming to early detect pump thrombosis or driveline infections. Since not all complications are reflected by pump parameters, data from different sources should be combined to detect a broader spectrum of complications in an early stage. We need to focus on the development of sophisticated but understandable algorithms and infrastructure combining different data sources, while addressing essential aspects such as data safety, privacy, and cost-effectiveness.
KW - LVAD
KW - Left ventricular assist device
KW - algorithms
KW - circadian rhythm
KW - prediction
KW - remote monitoring
UR - http://www.scopus.com/inward/record.url?scp=85140900553&partnerID=8YFLogxK
U2 - 10.1080/17434440.2022.2132147
DO - 10.1080/17434440.2022.2132147
M3 - Review article
C2 - 36285341
SN - 1743-4440
VL - 19
SP - 677
EP - 685
JO - Expert Review of Medical Devices
JF - Expert Review of Medical Devices
IS - 9
ER -